Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Specialty Devices
Drug Delivery Devices
Return to: MDBR Home | Specialty Devices | Drug Delivery Devices

Nemko certifies PCIB laser system

MDBR Staff Writer Published 03 January 2012

Nemko, a Norway-based notified body, has certified and granted CE mark to PCI Biotech's (PCIB) PCI 652nm laser.

PCIB said its PCI 652nm laser will be used in the Phase II study of Amphinex in head and neck cancer patients.

PCIB develops light directed drug delivery system based on the company's patented photochemical internalisation (PCI) technology.

Based on the company's PCI technology, the company follows a dual strategy to improve the effect both of existing drugs and gene therapy treatments.

Comments
Post a comment

Comments may be moderated for spam, obscenities or defamation.